Thermo Fisher Scientific Inc (BSP:TMOS34)
R$ 66.95 0.16 (0.24%) Market Cap: 1.24 Tn Enterprise Value: 1.41 Tn PE Ratio: 34.91 PB Ratio: 4.35 GF Score: 79/100

Thermo Fisher Scientific Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 12:00AM GMT
Release Date Price: R$28.74
Tycho W. Peterson
JP Morgan Chase & Co, Research Division - Senior Analyst

Okay. Good afternoon. We're going to go ahead and get started. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this afternoon, Thermo Fisher Scientific. We're going to do a breakout right after in the Borgia Room, which is across the home. And with that, let me turn it over to Marc Casper.

Marc N. Casper
Thermo Fisher Scientific Inc. - CEO, President & Director

Tycho, thank you. Nice to see everybody here in San Francisco to kick off what I know will be another special year for Thermo Fisher Scientific.

The format of our presentation will be similar to years past. I'll give you an update on the company, review our progress against the goals that we highlighted at this conference at the beginning of 2019, and then I'll end with a talk to what are our goals for the future, and we'll follow that up with our financial guidance that we'll give in a few weeks' time during our earnings call.

So starting with the safe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot